Mark O’Neill is the Marketing Team Leader for Pfizer’s abuse-deterrent opioids portfolio. He passionately believes that everyone can play a role in addressing the opioid problem and has actively shared insights to help reduce the number of opioids in our communities.
Mark has been with Pfizer since 2001 and has help positions in US public affairs and policy and global policy, where he identified important policy changes in both smoking cessation and anaphylaxis treatment that enhanced patient access to medicines – and in marketing where we managed various businesses.
Mark has an undergraduate degree from the University of Delaware and an MBA from Rutgers University. He and his wife currently reside in Oceanport, NJ